Multiple sclerosis: Advances in diagnosis, biomarkers, and disease management

This publication has 52 references indexed in Scilit:

• Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System
  Immunity, Inflammation and Disease, 2025
• From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis
  Annals of Neurology, 2025
• Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
  JAMA Neurology, 2025
• Pathways to Progressive Disability in Multiple Sclerosis: The Role of Glial Cells in Chronic CNS Inflammation
  Glia, 2025
• Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
  Annals of Clinical and Translational Neurology, 2023
• Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors
  JAMA Neurology, 2023
• Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
  JAMA Neurology, 2023
• Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
  JAMA Neurology, 2020
• Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis
  Annals of Clinical and Translational Neurology, 2020
• Silent progression in disease activity–free relapsing multiple sclerosis
  Annals of Neurology, 2019